{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:14:13Z","timestamp":1790374453267,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,30]],"date-time":"2018-06-30T00:00:00Z","timestamp":1530316800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81600327"],"award-info":[{"award-number":["81600327"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12944-018-0801-x","type":"journal-article","created":{"date-parts":[[2018,6,30]],"date-time":"2018-06-30T13:35:56Z","timestamp":1530365756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["The influence of the intestinal microflora to the efficacy of Rosuvastatin"],"prefix":"10.1186","volume":"17","author":[{"given":"Lijun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zezhou","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keke","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,30]]},"reference":[{"key":"801_CR1","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","volume":"388","author":"GBD 2015 Mortality and Causes of Death Collaborators","year":"2016","unstructured":"GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388:1459\u2013544. https:\/\/doi.org\/10.1016\/S0140-6736(16)31012-1 .","journal-title":"Lancet"},{"key":"801_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004816.pub5.","volume":"1","author":"F Taylor","year":"2013","unstructured":"Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013;1:CD004816. https:\/\/doi.org\/10.1002\/14651858.CD004816.pub5.","journal-title":"Cochrane Database Syst Rev"},{"key":"801_CR3","volume-title":"Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease","author":"National Clinical Guideline Centre (UK)","year":"2014","unstructured":"National Clinical Guideline Centre (UK). Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. London: National Institute for Health and Care Excellence (UK); 2014."},{"key":"801_CR4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0022-2275(20)42221-7","volume":"21","author":"MS Brown","year":"1980","unstructured":"Brown MS, Goldstein JL. Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth. J Lipid Res. 1980;21:505\u201317.","journal-title":"J Lipid Res"},{"key":"801_CR5","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.2015.15629","volume":"316","author":"R Chou","year":"2016","unstructured":"Chou R, Dana T, Blazina I, Daeges M, Jeanne TL. Statins for prevention of cardiovascular disease in adults: evidence report and systematic review for the US preventive services task force. JAMA. 2016;316:2008\u201324. https:\/\/doi.org\/10.1001\/jama.2015.15629 .","journal-title":"JAMA"},{"key":"801_CR6","first-page":"11","volume":"6","author":"P Scicchitano","year":"2014","unstructured":"Scicchitano P, Cameli M, Maiello M, Modesti PA, Muiesan ML, Novo S, et al. Nutraceuticals and dyslipidaemia: beyond the common therapeutics. J functional. Foods. 2014;6:11\u201332.","journal-title":"Foods"},{"issue":"16","key":"801_CR7","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1080\/10408398.2016.1220913","volume":"57","author":"EB Daliri","year":"2017","unstructured":"Daliri EB, Wei S, Oh DH, Lee BH. The human microbiome and metabolomics: current concepts and applications. Crit Rev Food Sci Nutr. 2017;57(16):3565\u201376. https:\/\/doi.org\/10.1080\/10408398.2016.1220913 .","journal-title":"Crit Rev Food Sci Nutr"},{"key":"801_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025482","volume":"6","author":"R Kaddurah-Daouk","year":"2011","unstructured":"Kaddurah-Daouk R, Baillie RA, Zhu H, Zeng ZB, Wiest MM, Nguyen UT, et al. Enteric microbiome metabolites correlate with response to simvastatin treatment. PLoS One. 2011;6:e25482. https:\/\/doi.org\/10.1371\/journal.pone.0025482 .","journal-title":"PLoS One"},{"key":"801_CR9","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","volume":"284","author":"DJ Parks","year":"1999","unstructured":"Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, et al. Bile acids:natural ligands for an orphan nuclear receptor. Science. 1999;284:1365\u201378.","journal-title":"Science"},{"key":"801_CR10","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.imbio.2016.04.003","volume":"22","author":"X Luo","year":"2016","unstructured":"Luo X, Zheng Y, Wen R, Deng X, Zhou L, Liao H. Effects of ceftriaxone induced intestinal dysbacteriosis on lymphocytes in different tissues in mice. Immunobiology. 2016;22:994\u20131000. https:\/\/doi.org\/10.1016\/j.imbio.2016.04.003 .","journal-title":"Immunobiology"},{"key":"801_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7:27\u201331. https:\/\/doi.org\/10.4103\/0976-0105.177703 .","journal-title":"J Basic Clin Pharm"},{"key":"801_CR12","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.anaerobe.2005.05.001","volume":"11","author":"CL Sears","year":"2005","unstructured":"Sears CL. A dynamic partnership: celebrating our gut flora. Anaerobe. 2005;11:247\u201351.","journal-title":"Anaerobe"},{"key":"801_CR13","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1126\/science.1124234","volume":"312","author":"SR Gill","year":"2006","unstructured":"Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, et al. Metagenomic analysis of the human distal gut microbiome. Science. 2006;312:1355\u20139.","journal-title":"Science"},{"key":"801_CR14","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/0168-9525(90)90174-5","volume":"6","author":"FJ Gonzalez","year":"1990","unstructured":"Gonzalez FJ, Nebert DW. Evolution of the P450 gene superfamily: animal-plant \u2018warfare\u2019, molecular drive and human genetic differences in drug oxidation. Trends Genet. 1990;6:182\u20136.","journal-title":"Trends Genet"},{"key":"801_CR15","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1158\/0008-5472.CAN-16-2929","volume":"77","author":"S Thomas","year":"2017","unstructured":"Thomas S, Izard J, Walsh E, Batich K, Chongsathidkiet P, Clarke G, et al. The host microbiome regulates and maintains human health: a primer and perspective for non-microbiologists. Cancer Res. 2017;77:1783\u2013812. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-2929 .","journal-title":"Cancer Res"},{"key":"801_CR16","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","volume":"366","author":"C Baigent","year":"2005","unstructured":"Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267\u201378.","journal-title":"Lancet"},{"key":"801_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111247","volume":"9","author":"FM de Vries","year":"2014","unstructured":"de Vries FM, Kolthof J, Postma MJ, Denig P, Hak E. Efficacy of standard and intensive statin treatment for the secondary prevention of cardiovascular and cerebrovascular events in diabetes patients: a meta-analysis. PLoS One. 2014;9:e111247. https:\/\/doi.org\/10.1371\/journal.pone.0111247 .","journal-title":"PLoS One"},{"key":"801_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009763","volume":"5","author":"MJ Barber","year":"2010","unstructured":"Barber MJ, Mangravite LM, Hyde CL, Chasman DI, Smith JD, McCarty CA, et al. Genome-wide association of lipid-lowering response to statins in combined study populations. PLoS One. 2010;5:e9763. https:\/\/doi.org\/10.1371\/journal.pone.0009763 .","journal-title":"PLoS One"},{"key":"801_CR19","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1053\/euhj.2001.3071","volume":"23","author":"GR Thompson","year":"2002","unstructured":"Thompson GR, O'Neill F, Seed M. Why some patients respond poorly to statins and how this might be remedied. Eur Heart J. 2002;23:200\u20136.","journal-title":"Eur Heart J"},{"key":"801_CR20","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1124\/dmd.114.058354","volume":"42","author":"DH Yoo","year":"2014","unstructured":"Yoo DH, Kim IS, Van Le TK, Jung IH, Yoo HH, Kim DH. Gut microbiota-mediated drug interactions between lovastatin and antibiotics. Drug Metab Dispos. 2014;42:1508\u201313. https:\/\/doi.org\/10.1124\/dmd.114.058354 .","journal-title":"Drug Metab Dispos"},{"key":"801_CR21","first-page":"513","volume":"90","author":"A Damrongmanee","year":"2007","unstructured":"Damrongmanee A, Ukarapol N. Incidence of antibiotic-associated diarrhea in a pediatric ambulatory care setting. J Med Assoc Thail. 2007;90:513\u20137.","journal-title":"J Med Assoc Thail"},{"key":"801_CR22","first-page":"17","volume":"21","author":"DC Chen","year":"2009","unstructured":"Chen DC, Ma LQ, Liu SZ. Effects of rhubarb on intestinal flora and bacterial translocation in rats with sepsis. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2009;21:17\u201320.","journal-title":"Zhongguo Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"801_CR23","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/BF01645354","volume":"19","author":"GW Welling","year":"1991","unstructured":"Welling GW, Meijer-Severs GJ, Helmus G, van Santen E, Tonk RH, de Vries-Hospers HG, et al. The effect of ceftriaxone on the anaerobic bacter flora and the bacterial enzymatic activity in the intestinal tract. Infection. 1991;19:313\u20136.","journal-title":"Infection"},{"key":"801_CR24","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/1476-511X-10-126","volume":"10","author":"DC Cavallini","year":"2011","unstructured":"Cavallini DC, Suzuki JY, Abdalla DS, Vendramini RC, Pauly-Silveira ND, Roselino MN, et al. Influence of a probiotic soy product on fecal microbiota and its association with cardiovascular risk factors in an animal model. Lipids Health Dis. 2011;10:126. https:\/\/doi.org\/10.1186\/1476-511X-10-126 .","journal-title":"Lipids Health Dis"},{"key":"801_CR25","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00284-017-1230-1","volume":"74","author":"Y Liu","year":"2017","unstructured":"Liu Y, Zhao F, Liu J, Wang H, Han X, Zhang Y, et al. Selection of cholesterol-lowering lactic acid Bacteria and its effects on rats fed with high-cholesterol diet. Curr Microbiol. 2017;74:623\u201331. https:\/\/doi.org\/10.1007\/s00284-017-1230-1 .","journal-title":"Curr Microbiol"},{"key":"801_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3109\/09637486.2014.953450","volume":"66","author":"TP Singh","year":"2015","unstructured":"Singh TP, Malik RK, Katkamwar SG, Kaur G. Hypocholesterolemic effects of lactobacillus reuteri LR6 in rats fed on high-cholesterol diet. Int J Food Sci Nutr. 2015;66:71\u20135. https:\/\/doi.org\/10.3109\/09637486.2014.953450 .","journal-title":"Int J Food Sci Nutr"},{"key":"801_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6882-11-53","volume":"11","author":"N Xie","year":"2011","unstructured":"Xie N, Cui Y, Yin YN, Zhao X, Yang JW, Wang ZG, et al. Effects of two lactobacillus strains on lipid metabolism and intestinal microflora in rats fed a high-cholesterol diet. BMC Complement Altern Med. 2011;11:53. https:\/\/doi.org\/10.1186\/1472-6882-11-53 .","journal-title":"BMC Complement Altern Med"},{"key":"801_CR28","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1124\/dmd.114.058412","volume":"42","author":"A Kunze","year":"2014","unstructured":"Kunze A, Huwyler J, Camenisch G, Poller B. Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data. Drug Metab Dispos. 2014;42:1514\u201321. https:\/\/doi.org\/10.1124\/dmd.114.058412 .","journal-title":"Drug Metab Dispos"},{"key":"801_CR29","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1159\/000070669","volume":"99","author":"H Schuster","year":"2003","unstructured":"Schuster H. Rosuvastatin--a highly effective new 3- hydroxy-3-methylglutaryl coenzyme A reductase inhibitor: review of clinical trial data at 10\u201340 mg doses in dyslipidemic patients. Cardiology. 2003;99:126\u201339.","journal-title":"Cardiology"},{"key":"801_CR30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.femsle.2004.10.042","volume":"242","author":"P Veiga","year":"2005","unstructured":"Veiga P, Juste C, Lepercq P, Saunier K, B\u00e9guet F, G\u00e9rard P. Correlation between faecal microbial community structure and cholesterol-to-coprostanol conversion in the human gut. FEMS Microbiol Lett. 2005;242:81\u20136.","journal-title":"FEMS Microbiol Lett"},{"key":"801_CR31","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1124\/dmd.108.023630","volume":"37","author":"M Le Vee","year":"2009","unstructured":"Le Vee M, Lecureur V, Stieger B, Fardel O. Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6. Drug Metab Dispos. 2009;37:685\u201393. https:\/\/doi.org\/10.1124\/dmd.108.023630 .","journal-title":"Drug Metab Dispos"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-018-0801-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12944-018-0801-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-018-0801-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T20:25:04Z","timestamp":1661545504000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-018-0801-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,30]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["801"],"URL":"https:\/\/doi.org\/10.1186\/s12944-018-0801-x","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,30]]},"assertion":[{"value":"5 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the animal experiments were approved by the Animal ethics office of Xi\u2019an Jiaotong University. and consented for publication.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"151"}}